Silencing of SOCS-1 and SOCS-3 suppresses renal interstitial fibrosis by alleviating renal tubular damage in a rat model of hydronephrosis

Our study was performed to elucidate how SOCS-1/3 silencing suppresses renal interstitial fibrosis (RIF) by alleviating renal tubular damage in rat models affected by hydronephrosis. Male Wistar rats were randomly selected to establish hydronephrosis rat model, after which all rats were classified into normal, model, negative control (NC), siRNA-SOCS-1, siRNA-SOCS-3, and siRNA-SOCS-1+siRNA-SOCS-3 groups. The levels of urine protein, serum creatinine (Scr), and blood urea nitrogen (BUN) were detected. ELISA was performed to determine levels of cystatin (CysC), 2-microglobulin (2-MG), interleukin (IL)-6, and tumor necrosis factor (TNF)-. RT-qPCR and Western blotting were used for mRNA and protein expressions of SOCS-1, SOCS-3, -smooth muscle actin (-SMA), and transforming Growth Factor (TGF)-1. Compared with the normal group, the levels of Scr, BUN, urine protein, NAG, CysC, 2-MG, IL-6, and TNF- were increased in other groups, as well as elevated mRNA and protein expressions of SOCS-1, SOCS-3, -SMA, and TGF-1. The siRNA-SOCS-1, siRNA-SOCS-3, and siRNA-SOCS-1+siRNA-SOCS-3 groups were found with decreased levels of Scr, BUN, urine protein, NAG, CysC, 2-MG, IL-6, and TNF-, as well as mRNA and protein expressions of SOCS-1, SOCS-3, -SMA, and TGF-1, including positive rates of SOCS-1 and SOCS-3 proteins in comparison with the model and NC groups. In comparison with the siRNA-SOCS-1 and siRNA-SOCS-3 groups, the siRNA-SOCS-1+siRNA-SOCS-3 group exhibited decreased levels of Scr, BUN, urine protein, NAG, CysC, 2-MG, IL-6, and TNF-. Our study demonstrated that silencing of SOCS-1/3 may suppress RIF by alleviating the renal tubular damage in rat models affected by hydronephrosis.